Shuttle Pharmaceuticals Holdings (SHPH) Interest Coverage Ratio (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Interest Coverage Ratio of 182.88 in Q1 2026, down 330.33% quarter-over-quarter from 79.4 in Q4 2025, and up 66.57% on a YoY basis from 109.79 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 182.88 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 66.57% year-over-year to 182.88; the TTM figure through Mar 2026 stood at 568.79 (up 4516.78% YoY), while the FY2025 annual figure was 1365.04, down 54.17% from the prior year.
- Interest Coverage Ratio was 182.88 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from 79.4 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 190.7 in Q4 2022 to a low of 3144.16 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 388.74 across 5 years, with a median of 2.78 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 55572.6% in 2024, then soared 5216.88% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 190.7 in 2022, then tumbled by 101.26% to 2.41 in 2023, then soared by 161.94% to 1.49 in 2024, then jumped by 5216.88% to 79.4 in 2025, then sank by 330.33% to 182.88 in 2026.
- The last three Interest Coverage Ratio figures came in at 182.88 (Q1 2026), 79.4 (Q4 2025), and 3144.16 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 2.32 Mn | 1.26 Mn | - | -182.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.88 |
| Dec 31, 2025 | 79.40 |
| Sep 30, 2025 | -3,144.16 |
| Jun 30, 2025 | -1,495.95 |
| Mar 31, 2025 | -547.03 |
| Dec 31, 2024 | 1.49 |
| Sep 30, 2024 | -1,427.96 |
| Jun 30, 2024 | -3.44 |
| Mar 31, 2024 | -2.78 |
| Dec 31, 2023 | -2.41 |
| Sep 30, 2023 | -2.56 |
| Jun 30, 2023 | -2.01 |
| Mar 31, 2023 | -2.58 |
| Dec 31, 2022 | 190.70 |
| Sep 30, 2022 | -59.85 |
| Jun 30, 2022 | -2.08 |
| Mar 31, 2022 | -4.39 |
| Dec 31, 2021 | 12.92 |
| Sep 30, 2021 | -2,142.62 |